Verona Pharma Plc ADR (NASDAQ: VRNA) established initial surge of 3.48% at $15.75, before settling in for the price of $15.22 at the close. Taking a more long-term approach, VRNA posted a 52-week range of $11.83-$23.81.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -39.77%. Meanwhile, its Annual Earning per share during the time was 19.36%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -192.59%. This publicly-traded company’s shares outstanding now amounts to $80.44 million, simultaneously with a float of $59.93 million. The organization now has a market capitalization sitting at $1.22 billion. At the time of writing, stock’s 50-day Moving Average stood at $16.24, while the 200-day Moving Average is $16.76.
Verona Pharma Plc ADR (VRNA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Verona Pharma Plc ADR industry. Verona Pharma Plc ADR’s current insider ownership accounts for 22.62%, in contrast to 63.98% institutional ownership. According to the most recent insider trade that took place on Feb 05 ’24, this organization’s Chief Medical Officer sold 36,248 shares at the rate of 2.22, making the entire transaction reach 80,503 in total value, affecting insider ownership by 2,731,624. Preceding that transaction, on Nov 20 ’23, Company’s Director bought 33,736 for 1.84, making the whole transaction’s value amount to 61,973. This particular insider is now the holder of 144,800 in total.
Verona Pharma Plc ADR (VRNA) Earnings and Revenue Records
Verona Pharma Plc ADR’s EPS decrease for this current 12-month fiscal period is -192.59% and is forecasted to reach -0.07 in the upcoming year.
Verona Pharma Plc ADR (NASDAQ: VRNA) Trading Performance Indicators
Let’s observe the current performance indicators for Verona Pharma Plc ADR (VRNA). It’s Quick Ratio in the last reported quarter now stands at 33.33. The Stock has managed to achieve an average true range (ATR) of 0.60.
In the same vein, VRNA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.69, a figure that is expected to reach -0.06 in the next quarter, and analysts are predicting that it will be -0.07 at the market close of one year from today.
Technical Analysis of Verona Pharma Plc ADR (VRNA)
Now, what If we examine the latest scores posted by [Verona Pharma Plc ADR, VRNA]. During the last 5-days, its volume was lower the volume of 0.49 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 44.46% While, its Average True Range was 0.55.
Raw Stochastic average of Verona Pharma Plc ADR (VRNA) in the period of the previous 100 days is set at 29.55%, which indicates a major fall in contrast to 50.90% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 26.57% that was lower than 53.92% volatility it exhibited in the past 100-days period.
